APRE
Price
$1.68
Change
-$0.08 (-4.57%)
Updated
Jun 27 closing price
Capitalization
9.27M
MBRX
Price
$0.31
Change
-$0.01 (-3.12%)
Updated
Jun 27 closing price
Capitalization
4.41M
Interact to see
Advertisement

APRE vs MBRX

Header iconAPRE vs MBRX Comparison
Open Charts APRE vs MBRXBanner chart's image
Aprea Therapeutics
Price$1.68
Change-$0.08 (-4.57%)
Volume$53.58K
Capitalization9.27M
Moleculin Biotech
Price$0.31
Change-$0.01 (-3.12%)
Volume$4.26M
Capitalization4.41M
APRE vs MBRX Comparison Chart in %
Loading...
APRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APRE vs. MBRX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APRE is a Buy and MBRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (APRE: $1.67 vs. MBRX: $0.31)
Brand notoriety: APRE and MBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APRE: 136% vs. MBRX: 172%
Market capitalization -- APRE: $9.27M vs. MBRX: $4.41M
APRE [@Biotechnology] is valued at $9.27M. MBRX’s [@Biotechnology] market capitalization is $4.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APRE’s FA Score shows that 2 FA rating(s) are green whileMBRX’s FA Score has 0 green FA rating(s).

  • APRE’s FA Score: 2 green, 3 red.
  • MBRX’s FA Score: 0 green, 5 red.
According to our system of comparison, APRE is a better buy in the long-term than MBRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APRE’s TA Score shows that 5 TA indicator(s) are bullish while MBRX’s TA Score has 2 bullish TA indicator(s).

  • APRE’s TA Score: 5 bullish, 4 bearish.
  • MBRX’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, APRE is a better buy in the short-term than MBRX.

Price Growth

APRE (@Biotechnology) experienced а +2.45% price change this week, while MBRX (@Biotechnology) price change was +16.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APRE($9.27M) has a higher market cap than MBRX($4.41M). APRE YTD gains are higher at: -49.088 vs. MBRX (-81.635). APRE has higher annual earnings (EBITDA): -15.23M vs. MBRX (-25.78M). APRE has more cash in the bank: 19.3M vs. MBRX (7.72M). APRE has less debt than MBRX: APRE (0) vs MBRX (450K). APRE (0) and MBRX (0) have equivalent revenues.
APREMBRXAPRE / MBRX
Capitalization9.27M4.41M210%
EBITDA-15.23M-25.78M59%
Gain YTD-49.088-81.63560%
P/E RatioN/AN/A-
Revenue00-
Total Cash19.3M7.72M250%
Total Debt0450K-
FUNDAMENTALS RATINGS
MBRX: Fundamental Ratings
MBRX
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
39

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APREMBRX
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
N/A
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 21 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
77%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
APRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSFG24.290.23
+0.96%
First Savings Financial Group
TYL581.103.90
+0.68%
Tyler Technologies
AWX2.44-0.01
-0.40%
Avalon Holdings Corp
HIW31.11-0.19
-0.61%
Highwoods Properties
BRY2.84-0.03
-1.05%
Berry Corp

APRE and

Correlation & Price change

A.I.dvisor tells us that APRE and PRQR have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APRE and PRQR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APRE
1D Price
Change %
APRE100%
-4.42%
PRQR - APRE
30%
Poorly correlated
-5.56%
EYPT - APRE
29%
Poorly correlated
-7.04%
CABA - APRE
29%
Poorly correlated
-6.52%
ACET - APRE
28%
Poorly correlated
-6.71%
SCPH - APRE
28%
Poorly correlated
-2.76%
More

MBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBRX has been loosely correlated with EDSA. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if MBRX jumps, then EDSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBRX
1D Price
Change %
MBRX100%
-3.04%
EDSA - MBRX
33%
Loosely correlated
+5.03%
UNCY - MBRX
32%
Poorly correlated
+14.48%
DOMH - MBRX
29%
Poorly correlated
-5.93%
ACIU - MBRX
27%
Poorly correlated
-2.90%
APRE - MBRX
27%
Poorly correlated
-4.42%
More